News analysis for professionals in the cannabis industry

US Northeast cannabis and vaping summit aims at joint regulation

Written by CannIntelligence | 28th October 2019

Governors and lawmakers from six US states have met at a regional cannabis and vaping summit in an attempt to establish more collective standardised regulations and legislative approaches ...

Teething troubles as firms are warned over prohibited medical claims

Written by Freddie Dawson | 24th October 2019

Federal enforcement against CBD medical claims in the US is going strong, with the Federal Trade Commission (FTC) recently sending a warning letter to a new company about what it said were prohibited medical claims...

Colorado works on rules to ban additives linked to vaping scare

Written by CannIntelligence | 24th October 2019

Regulators in the US state of Colorado are preparing to finalise rules that ban certain additives in cannabinoid vaping liquids – but a question remains over who is to oversee and enforce those rules ...

CBD-Intel business news in brief

Written by CannIntelligence | 23rd October 2019

A legal battle between a Canadian cannabis company and a US hemp company leads this round-up of business news in brief. Also covered are stories from Australia, Germany, and a number of US states ...

Few complaints and little enforcement – but EU food rules still apply in UK

Written by CannIntelligence | 22nd October 2019

UK Trading Standards teams report very few complaints about food and drink containing CBD, despite the Food Standards Agency (FSA) saying it would follow EU rules, which say CBD should not be used as an...

Caution required when advertising food containing CBD, rules UK ASA

Written by Freddie Dawson | 22nd October 2019

Companies can advertise food and drinks as containing CBD, however, they should be careful about implying any link to illicit drugs like cannabis, according to the UK Advertising Standards Authority (ASA) ...

CBD producer gets whiff of a tie-up with flavours and fragrances firm

Written by CannIntelligence | 22nd October 2019

The world of CBD is set to get a surprising new entrant, if talks between Canada’s Neptune Wellness Solutions and International Flavors & Fragrances (IFF) of New York conclude satisfactorily ...

Quality control marks on the way for CBD – but will anyone notice?

Written by CannIntelligence | 18th October 2019

At least three organisations involved in CBD and hemp are setting up marks to let consumers know their products meet minimum quality standards. However, according to one expert, many customers won’t even notice them ...

Research reveals how CBD offsets mentally disturbing effects of THC

Written by CannIntelligence | 17th October 2019

Researchers in Canada have for the first time revealed how CBD can block unwanted THC-related side-effects of cannabis. Also: Can CBD relieve anxiety disorders? and the therapeutic potential of ‘Turbo’ oil tested ...

US health organisations respond to rise of CBD with cautious optimism

Written by Lorraine Mullaney | 17th October 2019

Medical associations in the US say they are optimistic about the potential for CBD to treat patients, but have warned people to proceed with caution when treating themselves due to a lack of rigorous scientific...

Improved extraction techniques ‘could open up new markets’

Written by CannIntelligence | 16th October 2019

CBD with legally-permitted levels of psychotropic elements can be derived from varieties containing higher levels of THC using better extraction techniques, according to an industry expert ...

CBD firms are urged to scrub up on farming, testing and ‘hollow claims’

Written by CannIntelligence | 16th October 2019

Leading CBD sellers in the US have been urged to clean up their act by the Center for Food Safety (CFS) after a “scorecard” survey revealed supply chain failings – from farm to point of...

CBD and medical cannabis the ‘most interesting’ areas of Euro market

Written by CannIntelligence | 16th October 2019

Cannabis industry stakeholders are most interested in CBD – both in and out of medical context – according to an executive in the European arm of a cross-trading platform ...

US universities take positive steps for hemp research and innovation

Written by Lorraine Mullaney | 15th October 2019

Funding success for new developments in hemp research, as well as innovations such as monitoring the path of pollen using drones ...

Swedish court rules CBD does not make a product pharmaceutical

Written by CannIntelligence | 14th October 2019

A Swedish court has ruled that a product containing CBD for oral consumption cannot automatically be classified as a pharmaceutical, but that the legal status of each product must be assessed individually ...

Sportspeople shown to be effective for endorsing CBD products – for now

Written by CannIntelligence | 10th October 2019

The relative newness of CBD means brands will look to get big names to endorse it – but as the product becomes more known and accepted, this could all change ...

Trials test link between marijuana and autism: CBD-Intel news in brief

Written by CannIntelligence | 9th October 2019

CBD-Intel brings you business and related news in brief from the US, China, Israel and UK ...

CBD across the US still caught up in a tangle of inconsistent enforcement

Written by CannIntelligence | 8th October 2019

Despite various bodies making steps towards legalisation, the existing legal environment for CBD across the US remains a patchwork of contradictory policies ...

Lung outbreak: CDC, FDA now focused on THC, but public more worried by nicotine

Written by Lorraine Mullaney | 4th October 2019

The American public believes nicotine e-cigarettes to be more dangerous than THC vaping, even as official statements on the recent outbreak of lung disease start to emphasise the role of cannabis and play down the...

Salvini’s gone and his ‘war’ is over – so what happens next for CBD in Italy?

Written by CannIntelligence | 30th September 2019

Uncertainty over the legal status and future of CBD in Italy is affecting the way some manufacturers prepare and label their products, according to a senior executive in the industry ...

CBD-Intel regulatory news in brief, 26th-30th September

Written by CannIntelligence | 30th September 2019

Moves are under way in a number of US states to take executive action against various vapour products. Meanwhile, a Kentucky CBD firm is suing for $44m an Oregon company it says sold it “nearly...

£9m Love Hemp purchase could be a sign of things to come in UK market

Written by CannIntelligence | 30th September 2019

The purchase of a British CBD company by a medical cannabis investment firm could be just one of many to come, according to industry experts ...

CBD-Intel business news in brief

Written by CannIntelligence | 26th September 2019

A San Francisco-based CBD firm is donating all September profits from its bestselling line to Leonardo DiCaprio’s Earth Alliance Amazon Forest Fund. This and other business news in brief ...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 26th September 2019

This bonus edition of CBD-Intel regulatory news in brief includes items from across North and South America as well as Europe and Australia ...

SAFE Banking Act safely through the US House, but obstacles remain

Written by CannIntelligence | 26th September 2019

Passage of the Secure and Fair Enforcement (SAFE) Banking Act through the US House of Representatives is but one skirmish, with a potentially fiercer battle awaiting in the Senate and the White House ...

Good evidence – and the lack of it: CBD-Intel science news in brief

Written by Lorraine Mullaney | 25th September 2019

Scientific studies reveal varying views on the use of CBD and cannabis in treating PTSD, HIV, depression, anxiety and stress, while parents are warned not to give CBD to their children ...

Malaysia looks to begin research into medical cannabis

Written by CannIntelligence | 24th September 2019

The Malaysian government is to allow the import, storage, distribution and sale of medical marijuana – as long as producers or importers can prove its safety and efficacy for medical use ...

How the Tupperware party technique is spreading the word about CBD

Written by CannIntelligence | 24th September 2019

Multi-level marketing of cannabidiol is booming in the US and Europe, with forecasts for the market to continue expanding. There are advantages to the system – and challenges ...

US lung outbreak: despite likely role of THC, most still blame vaping itself

Written by David Palacios | 23rd September 2019

The cannabis and CBD sectors have thus far remained remarkably unscathed by the lung illness outbreak in the US, despite a growing suspicion that in at least many cases, the culprit may be THC oil...

CBD-based epilepsy drug Epidyolex gets the green light from Europe

Written by Barnaby Page | 23rd September 2019

Epidyolex, the CBD-based medicine used to treat rare forms of epilepsy, has been approved by the European Medicines Agency (EMA) ...

US Senate committee allocates cash to speeding up CBD regulation

Written by CannIntelligence | 23rd September 2019

US Senate majority leader Mitch McConnell is to attach funding to the agricultural appropriations bill to speed the FDA’s preliminary steps towards rulemaking for CBD products ...

Botanic Lab and Deliveroo combine to create 'CBD on demand' in London

Written by CannIntelligence | 20th September 2019

CBD users in parts of London will have the chance to get cannabidiol soft drinks without leaving their homes after drinks company Botanic Lab announced a partnership with home delivery firm Deliveroo, creating what they...

Quebec plans to defy edibles and topicals legalisation in Canada

Written by CannIntelligence | 20th September 2019

As Canada prepares for the legalisation of cannabis edibles and topical creams this autumn, one province wants to restrict them. Quebec has served notice that it plans to adopt its own set of regulations banning...

Study urges patients, physicians and CBD users to consider the evidence

Written by Lydia Thompson | 19th September 2019

A new review of CBD science from the Mayo Clinic in the US aims to help doctors prescribe “evidence-based formulations” ...

Experts pour scorn on plan to grow hemp on Ireland’s ancient peat bogs

Written by CannIntelligence | 19th September 2019

Experts have criticised plans by the Irish government to turn the country’s dwindling peat bogs into hemp farms that could produce the raw material for CBD products ...

Britain's CBD market: understanding key brand and consumer trends

Written by CannIntelligence | 18th September 2019

CBD-Intel managing director Tim Phillips gave an informative presentation to visitors to the Hemp & CBD Expo in Birmingham, UK, on 15th September 2019. The talk covered the UK market in general, plus the results of...

CBD-Intel regulatory news in brief, 10th-16th September

Written by CannIntelligence | 16th September 2019

Regulatory developments from the US, EU, Germany, Italy, India, Israel and Myanmar – and news of an “illegal” incursion into Austria by undercover Swiss border guards ...

As Birmingham City fans get CBD drink, will players get supplements?

Written by CannIntelligence | 12th September 2019

A professional football club from England’s second highest division could give its players CBD supplements after tying up a deal with a local CBD company ...

NFL’s brightest stars come out for CBD – the league’s chief medic still says no

Written by CannIntelligence | 12th September 2019

The chief medical officer of the US National Football League (NFL) remains wary of letting players use CBD, despite a number of stars coming forward to endorse it ...

Raided German CBD sellers left in limbo with no legal charges yet

Written by CannIntelligence | 10th September 2019

Five months after police in Bavaria and Baden-Württemberg raided CBD shops and confiscated goods worth hundreds of thousands of euros, no charges have yet been filed ...

CBD-Intel business news in brief

Written by CannIntelligence | 10th September 2019

From US over-production to European and Chinese expansion plans, via CBD toothpicks, sports star promotions and threatened job losses ...

CBD regulatory news in brief, 3rd - 9th September

Written by CannIntelligence | 9th September 2019

South Dakota governor Kristi Noem has explained why she continues to oppose hemp legalisation in the state; Flanders in Belgium is seeing enforcement action against CBD shops because of CBD oils and teas; Australian state...

California hemp bill delays legalisation of foods, beverages and cosmetics with hemp-based CBD

Written by Freddie Dawson | 9th September 2019

The launch of many CBD-containing foods, beverages and cosmetics in California has been delayed further as a bill legalising their sale is now not expected to pass before the end of the legislative session, which...

Curaleaf takes action on FDA complaint over health claims

Written by Freddie Dawson | 5th September 2019

Curaleaf, a US-based vendor of CBD products with a presence in 12 states, has responded to warnings made by the FDA about its marketing of CBD products ...

A step forward as US DEA expands cannabinoid scientific research

Written by Freddie Dawson | 5th September 2019

The US Drug Enforcement Agency has decided to expand cannabinoid scientific research and no longer requires registration for the growth or research of hemp ...

Russia poised to open up to CBD after Duma agrees to lift cultivation ban

Written by CannIntelligence | 5th September 2019

Despite continuing uncertainty, the Russian CBD market is on the verge of big changes, following the approval of a draft bill by the national parliament ...

CBD-Intel regulatory news in brief, 27th August-2nd September

Written by CannIntelligence | 2nd September 2019

Americans for Safe Access has issued the Patient’s Guide to CBD, Ireland sees increase in hemping-growing licence applications, and over 6000 plants have been seized in Portugal ...

CBD-Intel business news in brief, 24th-31st August

Written by CannIntelligence | 2nd September 2019

Information from the US, the UK, Canada and Africa, including how more than half of the hemp crops planted in Hawaii have had to be destroyed due to THC content being over the permitted levels...

CBD drug Epidyolex looks unlikely to get a NICE answer in the UK

Written by CannIntelligence | 29th August 2019

The panel largely responsible for recommending which drugs the UK’s National Health Service (NHS) should provide may discourage use of the CBD-based drug Epidyolex ...

UK flower-grower switching to hemp following takeover by Canadians

Written by CannIntelligence | 27th August 2019

UK ornamental flowers producer the Bridge Farm Group says it will focus on hemp and CBD following its recent acquisition by Canadian cannabis company Sundial Growers ...

LATEST ALERTS

Written by CannIntelligence | 28th October 2019

Written by Freddie Dawson | 24th October 2019

Written by CannIntelligence | 24th October 2019

Written by CannIntelligence | 23rd October 2019

Written by CannIntelligence | 22nd October 2019

Written by Freddie Dawson | 22nd October 2019

Written by CannIntelligence | 22nd October 2019

Written by CannIntelligence | 18th October 2019

Written by CannIntelligence | 17th October 2019

Written by Lorraine Mullaney | 17th October 2019

Written by CannIntelligence | 16th October 2019

Written by CannIntelligence | 16th October 2019

Written by CannIntelligence | 16th October 2019

Written by Lorraine Mullaney | 15th October 2019

Written by CannIntelligence | 14th October 2019

Written by CannIntelligence | 10th October 2019

Written by CannIntelligence | 9th October 2019

Written by CannIntelligence | 8th October 2019

Written by Lorraine Mullaney | 4th October 2019

Written by CannIntelligence | 30th September 2019

Written by CannIntelligence | 30th September 2019

Written by CannIntelligence | 30th September 2019

Written by CannIntelligence | 26th September 2019

Written by CannIntelligence | 26th September 2019

Written by CannIntelligence | 26th September 2019

Written by Lorraine Mullaney | 25th September 2019

Written by CannIntelligence | 24th September 2019

Written by CannIntelligence | 24th September 2019

Written by David Palacios | 23rd September 2019

Written by Barnaby Page | 23rd September 2019

Written by CannIntelligence | 23rd September 2019

Written by CannIntelligence | 20th September 2019

Written by CannIntelligence | 20th September 2019

Written by Lydia Thompson | 19th September 2019

Written by CannIntelligence | 19th September 2019

Written by CannIntelligence | 18th September 2019

Written by CannIntelligence | 16th September 2019

Written by CannIntelligence | 12th September 2019

Written by CannIntelligence | 12th September 2019

Written by CannIntelligence | 10th September 2019

Written by CannIntelligence | 10th September 2019

Written by CannIntelligence | 9th September 2019

Written by Freddie Dawson | 9th September 2019

Written by Freddie Dawson | 5th September 2019

Written by Freddie Dawson | 5th September 2019

Written by CannIntelligence | 5th September 2019

Written by CannIntelligence | 2nd September 2019

Written by CannIntelligence | 2nd September 2019

Written by CannIntelligence | 29th August 2019

Written by CannIntelligence | 27th August 2019

Sign up to our newsletter

Start your FREE trial